HUP0104002A2 - alfa2-Antagonista triciklusos delta3-piperidinek, eljárás előállításukra, ilyen vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk gyógyszerként - Google Patents
alfa2-Antagonista triciklusos delta3-piperidinek, eljárás előállításukra, ilyen vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk gyógyszerkéntInfo
- Publication number
- HUP0104002A2 HUP0104002A2 HU0104002A HUP0104002A HUP0104002A2 HU P0104002 A2 HUP0104002 A2 HU P0104002A2 HU 0104002 A HU0104002 A HU 0104002A HU P0104002 A HUP0104002 A HU P0104002A HU P0104002 A2 HUP0104002 A2 HU P0104002A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- compounds
- alpha2
- piperidines
- medicament
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 229940104915 Alpha 2 adrenoreceptor antagonist Drugs 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 abstract 1
- 239000012965 benzophenone Substances 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- -1 phenoxyphenyl Chemical group 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000169 tricyclic heterocycle group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Gynecology & Obstetrics (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
A találmány központi a2-adrenoreceptor-antagonista aktivitássalrendelkező (I) általános képletű vegyületekre, ezek N-oxidjaira,gyógyászatilag elfogadható addíciós sóira és sztereokémiai izomereirevonatkozik, ahol a képletben Alk jelentése 1-6 szénatomosalkándiilcsoport; n értéke 1 vagy 2; X1 jelentése -O-, -S-, -S(=O)-vagy -S(=O)2-; R1 jelentése minden esetben egymástól függetlenülhidrogénatom, halogénatom, 1-6 szénatomos alkilcsoport, nitrocsoport,hidroxilcsoport, 1-4 széntomos alkil-oxi-csoport; D jelentése mono-,bi- vagy triciklusos, nitrogénatomot tartalmazó heterociklus, 2H-benzopiranon-, benzamid-, benzofenon- vagy fenoxi-fenil-csoport. Atalálmány továbbá e vegyületek előállítási eljárására, ilyenvegyületeket tartalmazó gyógyászati készítményekre, valamintgyógyszerként történő alkalmazásukra vonatkozik. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98203370 | 1998-10-06 | ||
| PCT/EP1999/007419 WO2000020421A2 (en) | 1998-10-06 | 1999-10-01 | TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0104002A2 true HUP0104002A2 (hu) | 2002-03-28 |
| HUP0104002A3 HUP0104002A3 (en) | 2003-12-29 |
Family
ID=8234191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0104002A HUP0104002A3 (en) | 1998-10-06 | 1999-10-01 | Alpha2-antagonists tricyclic delta3-piperidines, process for their producing the pharmaceutical compositions containing them and their use as medicament |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6495555B1 (hu) |
| EP (1) | EP1119571B1 (hu) |
| JP (1) | JP4590101B2 (hu) |
| KR (1) | KR20010071843A (hu) |
| CN (1) | CN1131230C (hu) |
| AR (1) | AR024216A1 (hu) |
| AT (1) | ATE232869T1 (hu) |
| AU (1) | AU760502B2 (hu) |
| BG (1) | BG64872B1 (hu) |
| BR (1) | BR9913507A (hu) |
| CA (1) | CA2345622C (hu) |
| CZ (1) | CZ20011104A3 (hu) |
| DE (1) | DE69905478T2 (hu) |
| DK (1) | DK1119571T3 (hu) |
| EE (1) | EE04770B1 (hu) |
| ES (1) | ES2193751T3 (hu) |
| HK (1) | HK1038010A1 (hu) |
| HU (1) | HUP0104002A3 (hu) |
| ID (1) | ID28032A (hu) |
| IL (1) | IL142443A0 (hu) |
| NO (1) | NO20011270L (hu) |
| NZ (1) | NZ510115A (hu) |
| PL (1) | PL347894A1 (hu) |
| PT (1) | PT1119571E (hu) |
| RU (1) | RU2230744C2 (hu) |
| SI (1) | SI1119571T1 (hu) |
| SK (1) | SK285585B6 (hu) |
| TR (1) | TR200100952T2 (hu) |
| TW (1) | TWI248441B (hu) |
| UA (1) | UA69420C2 (hu) |
| WO (1) | WO2000020421A2 (hu) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID28451A (id) * | 1998-10-06 | 2001-05-24 | Janssen Pharmaceutica Nv | Trisiklik piperidin-δ3 sebagai bahan farmasi |
| ES2367481T3 (es) * | 2002-04-03 | 2011-11-03 | Orion Corporation | Uso de un antagonista del adrenoreceptor alfa2 para enfermedades relacionadas con el snc. |
| MXPA06011777A (es) | 2004-04-12 | 2007-01-16 | Taisho Pharma Co Ltd | Compuesto de amina ciclico. |
| US20060035939A1 (en) * | 2004-07-14 | 2006-02-16 | Japan Tobacco Inc. | 3-Aminobenzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR1) activity |
| BRPI0513286A (pt) * | 2004-07-15 | 2008-05-06 | Japan Tobacco Inc | compostos de benzamida condensada e inibidores de atividade de receptor vanilóide subtipo (vr1), suas composições farmacêuticas, pacote comercial, fármaco e respectivos usos |
| US7906508B2 (en) * | 2005-12-28 | 2011-03-15 | Japan Tobacco Inc. | 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (VRI) activity |
| EP2430019B1 (en) | 2009-05-14 | 2013-09-18 | Janssen Pharmaceutica, N.V. | Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase |
| JP2017501164A (ja) * | 2013-12-19 | 2017-01-12 | バイエル ファーマ アクチエンゲゼルシャフト | 置換されたピペリジニルテトラヒドロキノリン類 |
| JOP20200052A1 (ar) * | 2013-12-19 | 2017-06-16 | Bayer Pharma AG | بيبريدينيل تتراهيدرو كوينولينات مستبدلة واستخدامها كمعضدات مستقبل أدريني ألفا- 2c |
| CA2934134A1 (en) | 2013-12-19 | 2015-06-25 | Bayer Pharma Aktiengesellschaft | Substituted bipiperidinyl derivatives as adrenoreceptor alpha 2c antagonists |
| CN114276359B (zh) * | 2022-01-05 | 2023-05-05 | 浙江大学 | 一种1,2,3,4-四氢苯并[4,5]呋喃[2,3-c]吡啶衍生物的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3522959A1 (de) | 1985-06-27 | 1987-01-08 | Merck Patent Gmbh | Indolderivate |
| US4673680A (en) * | 1985-09-18 | 1987-06-16 | Pendleton Robert G | α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility |
| US4985422A (en) * | 1988-04-27 | 1991-01-15 | Glaxo Group Limited | Lactam derivatives |
| US4971974A (en) * | 1988-06-16 | 1990-11-20 | Neurex Corporation | Benzothiophenes as appetite suppressants |
| US5100891A (en) * | 1991-01-18 | 1992-03-31 | Hoechst-Roussel Pharmaceuticals Inc. | Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds |
| AU735764B2 (en) * | 1996-12-06 | 2001-07-12 | Abbott Laboratories | Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds |
| KR100588249B1 (ko) | 1997-12-25 | 2006-06-13 | 메이지 세이카 가부시키가이샤 | 테트라하이드로벤즈인돌 유도체 |
| ID28451A (id) * | 1998-10-06 | 2001-05-24 | Janssen Pharmaceutica Nv | Trisiklik piperidin-δ3 sebagai bahan farmasi |
-
1999
- 1999-01-10 UA UA2001031999A patent/UA69420C2/uk unknown
- 1999-10-01 ES ES99950627T patent/ES2193751T3/es not_active Expired - Lifetime
- 1999-10-01 PT PT99950627T patent/PT1119571E/pt unknown
- 1999-10-01 RU RU2001111812/04A patent/RU2230744C2/ru not_active IP Right Cessation
- 1999-10-01 US US09/806,547 patent/US6495555B1/en not_active Expired - Lifetime
- 1999-10-01 CZ CZ20011104A patent/CZ20011104A3/cs unknown
- 1999-10-01 CA CA002345622A patent/CA2345622C/en not_active Expired - Fee Related
- 1999-10-01 DE DE69905478T patent/DE69905478T2/de not_active Expired - Lifetime
- 1999-10-01 AT AT99950627T patent/ATE232869T1/de not_active IP Right Cessation
- 1999-10-01 WO PCT/EP1999/007419 patent/WO2000020421A2/en not_active Application Discontinuation
- 1999-10-01 SK SK432-2001A patent/SK285585B6/sk unknown
- 1999-10-01 NZ NZ510115A patent/NZ510115A/xx unknown
- 1999-10-01 PL PL99347894A patent/PL347894A1/xx not_active Application Discontinuation
- 1999-10-01 AU AU63341/99A patent/AU760502B2/en not_active Ceased
- 1999-10-01 DK DK99950627T patent/DK1119571T3/da active
- 1999-10-01 HU HU0104002A patent/HUP0104002A3/hu unknown
- 1999-10-01 EP EP99950627A patent/EP1119571B1/en not_active Expired - Lifetime
- 1999-10-01 CN CN99811682A patent/CN1131230C/zh not_active Expired - Fee Related
- 1999-10-01 ID IDW20010780A patent/ID28032A/id unknown
- 1999-10-01 SI SI9930264T patent/SI1119571T1/xx unknown
- 1999-10-01 TW TW088116898A patent/TWI248441B/zh not_active IP Right Cessation
- 1999-10-01 JP JP2000574533A patent/JP4590101B2/ja not_active Expired - Fee Related
- 1999-10-01 KR KR1020017000442A patent/KR20010071843A/ko active Search and Examination
- 1999-10-01 IL IL14244399A patent/IL142443A0/xx not_active IP Right Cessation
- 1999-10-01 BR BR9913507-8A patent/BR9913507A/pt not_active IP Right Cessation
- 1999-10-01 EE EEP200100209A patent/EE04770B1/xx not_active IP Right Cessation
- 1999-10-01 TR TR2001/00952T patent/TR200100952T2/xx unknown
- 1999-10-05 AR ARP990105038A patent/AR024216A1/es not_active Application Discontinuation
-
2001
- 2001-03-12 BG BG105332A patent/BG64872B1/bg unknown
- 2001-03-13 NO NO20011270A patent/NO20011270L/no not_active Application Discontinuation
- 2001-12-10 HK HK01108631A patent/HK1038010A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9305379A (es) | Nuevos derivados de aminoacidos, procedimiento para su preparacion y preparado farmaceutico que los contiene. | |
| HUP0101999A2 (hu) | 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása | |
| PT81814B (pt) | Processo para a preparacao de derivados de naftaleno | |
| SE9302080D0 (sv) | New compounds | |
| HUP0105437A2 (hu) | Új malonsavszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
| HUP0203312A2 (hu) | Farmakológiailag hatékony szulfonamidszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| HUP0402225A2 (hu) | Makrolid-vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| ES2160525B1 (es) | Derivados de la 4-aroilpiperidina antagonistas de los receptores ccr-3 | |
| HUP0104002A2 (hu) | alfa2-Antagonista triciklusos delta3-piperidinek, eljárás előállításukra, ilyen vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk gyógyszerként | |
| HUT45038A (en) | Process for producing 1,4-disubstituted piperazine derivatives and pharmaceuticals comprising the compounds | |
| HUP0101143A2 (hu) | Vitronektin receptor antagonista hatású piridin karbonsav származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
| HUP0003624A2 (hu) | 1,2,3,4-Tetrahidro-benzofuro[3,2-c]piridin-származékok, az ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra | |
| NO963655D0 (no) | Aminosyrederivater, fremgangsmåte for fremstilling av dem og farmasöytiske blandinger som inneholder dem | |
| BG105334A (en) | Tricyclic delta 3-piperidines as pharmaceuticals | |
| US2316051A (en) | Antispasmodic agents | |
| AR005472A1 (es) | Inhibidores de la formacion cd23 humana soluble, un procedimiento para su preparacion, el uso de los mismos para la manufactura de un medicamento,composicion farmaceutica y compuestos intermediarios | |
| HUP0103612A2 (hu) | Alfa2-antagonista benzotiofén[3,2-c]piridinek, eljárás előállításukra, ilyen vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk gyógyszerként | |
| ATE45958T1 (de) | Peptide, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung. | |
| HUP0202647A2 (hu) | Új arilalkanoilszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
| MY106235A (en) | New 2 - carbonyl substituted n, n'' -di (trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them. | |
| GR860045B (en) | Novel piperazine derivatives processes for production thereof and pharmaceutical compositions comprising said compounds as active ingredient | |
| HUP0104812A2 (hu) | Alfa2-antagonista hatású benzizoxazolok és fenonok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| UA34451C2 (uk) | 2,3,4,5-тетрагідро-1н-3-бензазепіни, що використовуються для лікування захворювань центральної нервової системи, спосіб їх одержання, фармацевтична композиція та спосіб лікування захворювань центральної нервової системи | |
| US3576000A (en) | Aminoether derivatives of 9,10-dihydro-9,10-ethano-9-anthrols and their salts | |
| US3553267A (en) | 3-dimethylamino-1,2,3,4-tetrahydrofluorene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |